|
SYRE Spyre Therapeutics Inc 1636282 |
| Balance Sheet |
|
Current Assets
|
421,079,000 |
|
Assets
|
421,089,000 |
|
Current Liabilities
|
57,539,000 |
|
Liabilities
|
93,699,000 |
|
Equity
|
327,390,000 |
|
Shares Out
|
50,920,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-120,211,000 |
|
Investing Cash Flow
|
-182,741,000 |
| Market Analysis |
Market Cap
|
1,476,534,180 |
|
Price
|
20.62 |
|
BVPS
|
6.43 |
|
PB
|
3.18 |
|
EPS
|
-15.42 |
|
PS
|
2.41 |
|
FCF
|
-302,952,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SYRE documents filed with the SEC.
SYRE Filings
Clear
